$0.00950
-0.00100-9.52%
At close: -
$0.0100
0.000505.26%
After Hours: Jan 8, 5:09 PM EDT
Comments
Loading...
Apollomics (APLMW) Forecast
NewsEarningsApollomics (APLMW) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestApollomics (NASDAQ:APLMW) Stock Quotes, Forecast and News Summary
Apollomics Stock (NASDAQ: APLMW) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Apollomics (APLMW) stock?
You can purchase shares of Apollomics (NASDAQ:APLMW) through any online brokerage.
Who are Apollomics (APLMW) competitors?
Other companies in Apollomics’s space includes: Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), Sarepta Therapeutics (NASDAQ:SRPT), BeiGene (NASDAQ:ONC) and Neurocrine Biosciences (NASDAQ:NBIX).
What is the forecast, or price target, for Apollomics (APLMW) stock?
There is no analysis for Apollomics to provide a consensus price target.
What is the current price for Apollomics (APLMW)?
The stock price for Apollomics (NASDAQ: APLMW) is $0.01 last updated January 8, 2025 at 5:09 PM EST.
Does Apollomics (APLMW) pay a dividend?
There are no upcoming dividends for Apollomics.
When is Apollomics (NASDAQ:APLMW) reporting earnings?
Apollomics does not have any upcoming earnings scheduled.
Is Apollomics (APLMW) going to split?
There is no upcoming split for Apollomics.
What sector and industry does Apollomics (APLMW) operate in?
Apollomics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.